RIGL - Rigel Pharmaceuticals - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

RIGL is currently covered by 4 analysts with an average price target of $61.83. This is a potential upside of $12.95 (26.49%) from yesterday's end of day stock price of $48.88.

Rigel Pharmaceuticals's activity chart (see below) currently has 113 price targets and 116 ratings on display. The stock rating distribution of RIGL is 25% HOLD and 75% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 45.75% with an average time for these price targets to be met of 734.95 days.

Highest price target for RIGL is $85, Lowest price target is $42, average price target is $61.83.

Most recent stock forecast was given by JOSEPH PANTGINIS from HC WAINWRIGHT. First documented stock forecast 21-Apr-2016.

Best performing analysts who are covering RIGL - Rigel Pharmaceuticals:

Gary Nachman Do Kim Eun Yang Kristen Kluska Allison Bratzel Kalpit Patel

Currently out of the existing stock ratings of RIGL, 2 are a HOLD (25%), 6 are a BUY (75%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Hold Since 02-Apr-2023

$49

$2.28 (4.88%)

$23

2 months 5 days ago
(16-Aug-2026)

3/3 (100%)

$6.55 (15.43%)

202

Buy Since 09-Mar-2023

$69

$30.31 (78.34%)

$67

11 months 17 days ago
(05-Nov-2025)

3/6 (50%)

$31.15 (82.30%)

819

Hold Since 06-May-2025

$42

$-4.72 (-10.10%)

$23

11 months 17 days ago
(04-Nov-2025)

4/11 (36.36%)

$4.15 (10.96%)

1547

Hold Since 10-Dec-2024

$32

$-6.69 (-17.29%)

$23

1 years 2 months 16 days ago
(06-Aug-2025)

4/5 (80%)

$2.19 (7.35%)

84

Show more analysts

Please expand the browser size to see the chart

What is RIGL (Rigel Pharmaceuticals) average time for price targets to be met?

On average it took 735 days for the stock forecasts to be reached, with an average price target met ratio of 45.75%.

Which analyst most recently updated their price target on RIGL (Rigel Pharmaceuticals)?

Joseph Pantginis

Which analyst has the most public recommendations on RIGL (Rigel Pharmaceuticals)?

Joseph Pantginis has 17 price targets and 16 ratings on RIGL

Which analyst is the currently most bullish on RIGL (Rigel Pharmaceuticals)?

Joshua Schimmer with the highest potential upside of $63.28

Which analyst is the currently most reserved on RIGL (Rigel Pharmaceuticals)?

Do Kim with the lowest potential downside of -$26.72
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?